Founded and headquartered in New York City, Kallyope is developing an industry-leading platform to harness the gut-brain axis.
View all
AnaptysBio
San Diego, United States · IPO
Applied StemCell
Milpitas, United States · Series D
Mammoth Biosciences
Brisbane, United States · Series D
Biofourmis
Boston, United States · Series D
Ecovative Design
Green Island, United States · Series D
ViaCyte
San Diego, United States · Series D
Akoya Biosciences
San Francisco, United States · Series D
Kymera Therapeutics
Watertown, United States · Post IPO Equity
StreetLight Data
San Francisco, United States · Series D
Papa
Hollywood, United States · Series D
Arcutis Biotherapeutics
Westlake Village, United States · Post IPO Debt
Form Energy
Somerville, United States · Grant